Fed. Circ. Upholds Ruling Axing Forest's Namenda Patents
The Federal Circuit on Monday affirmed a Delaware judge's decision that Forest Laboratories' six patents on the Alzheimer's drug Namenda are invalid as indefinite in a win for Teva Pharmaceuticals USA...To view the full article, register now.
Already a subscriber? Click here to view full article